Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.43 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.42 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | FBP1 | P09467 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5184996 | 0.81 | CES1 (0.55) | CES2CES1AKR1B1HIF1AALDH1A1 | |
| SCHEMBL10675970 | 0.79 | MCL1 (0.44) | CYP3A4CYP2C9GRIN1GRIN2BMCL1 | |
| SCHEMBL29720911 | 0.77 | CYP3A4 (0.59) | CYP3A4CYP2C9CES2CES1AKR1B1 | |
| SCHEMBL8286966 | 0.77 | MCL1 (0.42) | CYP3A4CYP2C9GRIN1GRIN2BMCL1 | |
| SCHEMBL3473792 | 0.77 | CES1 (0.46) | CYP3A4CYP2C9CES2CES1AKR1B1 | |
| SCHEMBL31568852 | 0.77 | CTSL (0.47) | CYP3A4CYP2C9CES2CES1AKR1B1 | |
| SCHEMBL18768682 | 0.77 | CES2 (0.46) | CYP3A4CYP2C9CES2CES1AKR1B1 | |
| SCHEMBL28105611 | 0.77 | FBP1 (0.45) | CYP3A4CYP2C9GRIN1GRIN2BMCL1 | |
| SCHEMBL4776145 | 0.76 | CYP3A4 (0.73) | CYP3A4CYP2C9CES2CES1AKR1B1 | |
| SCHEMBL6432268 | 0.76 | CYP3A4 (0.73) | CYP3A4CYP2C9CES2CES1AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1001816-A4 | PERFLUORINATED-ETHER COMPOSITIONS AS DIAGNOSTIC CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP (US) | 2002-07-17 | — | — | EP | claimed |
| EP-1001816-A1 | PERFLUORINATED-ETHER COMPOSITIONS AS DIAGNOSTIC CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 2000-05-24 | — | — | EP | claimed |
| WO-1998023298-A1 | PERFLUORINATED-ETHER COMPOSITIONS AS DIAGNOSTIC CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 1998-06-04 | — | — | WO | claimed |
| CN-114749160-B | Adsorption material for efficiently and stably removing aldehydes in epoxypropane and preparation method thereof | 福州大学 | 2023-06-16 | — | — | CN | disclosed |
| CN-114749160-A | Adsorbing material for efficiently and stably removing aldehydes in epoxypropane and preparation method thereof | 福州大学 | 2022-07-15 | — | — | CN | disclosed |
| CN-107847445-A | Encapsulated gas or partial vacuum CT contrast material | 加利福尼亚大学董事会 | 2018-03-27 | — | — | CN | disclosed |
| EP-3129464-A2 | METHODS, COMPOSITIONS, AND SYSTEMS FOR ACTIVATION AND EXPANSION OF CELLS | The Trustees of Columbia University in the City of New York (US) | 2017-02-15 | — | — | EP | disclosed |
| WO-2015157664-A2 | METHODS, COMPOSITIONS, AND SYSTEMS FOR ACTIVATION AND EXPANSION OF CELLS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2015-10-15 | — | — | WO | disclosed |
| WO-2011087521-A1 | CHEMILUMINESCENT DYES AND DYE-STAINED PARTICLES | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2011-07-21 | — | — | WO | disclosed |
| EP-0930844-B8 | IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT | LANTHEUS MEDICAL IMAGING INC (US) | 2008-11-26 | — | — | EP | disclosed |
| CN-1662487-A | Amide linker peroxisome proliferator-activated receptor modulators | LILLY CO ELI (US) | 2005-08-31 | — | — | CN | disclosed |
| EP-0930844-A1 | IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT | IMARX PHARMACEUTICAL CORP. (US) | 1999-07-28 | — | — | EP | disclosed |
| WO-1999013919-A1 | NOVEL TARGETED CONTRAST AGENTS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1999-03-25 | — | — | WO | disclosed |
| WO-1998050040-A1 | NOVEL LIPID SOLUBLE STEROID PRODRUGS | IMARX PHARMACEUTICAL CORP. (US) | 1998-11-12 | — | — | WO | disclosed |
| WO-1998050041-A1 | NOVEL PRODRUGS COMPRISING FLUORINATED AMPHIPHILES | IMARX PHARMACEUTICAL CORP. (US) | 1998-11-12 | — | — | WO | disclosed |
| WO-1998048838-A1 | COMPOUNDS | NYCOMED IMAGING AS (NO) | 1998-11-05 | — | — | WO | disclosed |
| WO-1998042384-A1 | METHODS FOR DELIVERING BIOACTIVE AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 1998-10-01 | — | — | WO | disclosed |
| EP-0831932-A1 | NOVEL TARGETED COMPOSITIONS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1998-04-01 | — | — | EP | disclosed |
| WO-1997048337-A1 | IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT | IMARX PHARMACEUTICAL CORP. (US) | 1997-12-24 | — | — | WO | disclosed |
| WO-1996040285-A1 | NOVEL TARGETED COMPOSITIONS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1996-12-19 | — | — | WO | disclosed |